comparemela.com
Home
Live Updates
Enrolment completed in Actinogen's XanaCIDD phase 2a cogniti
Enrolment completed in Actinogen's XanaCIDD phase 2a cogniti
Enrolment completed in Actinogen's XanaCIDD phase 2a cognition & depression trial
Trial results anticipated in early Q3 this year
Related Keywords
Thailand ,
Sydney ,
New South Wales ,
Australia ,
,
Actinogen Medical Limited ,
Company Xana ,
Actinogen Medical ,
Dana Hilt Actinogen ,
Chief Medical Officer ,
Montgomery Asberg Depression Rating Scale ,
Fragilex Syndrome ,
Thailand Business ,